<prompt> All of the following pharmacological agents may be used for reducing risk of contrast nephropathy, except:FenoldopamN-AcetylcysteineProstaglandinsFurosemide  <response>: Answer is D Furosemide: Use of Furosemide may be potentially detrimental in patients with Contrast Induced Nephropathy CIN and is not recommended. The CIN Consensus Working Panel : Summary: Conclusion Positive results Potentially beneficial TheophyllineaminophvIline Statins Ascorbic acid Prostaglandin El Neutral results No consistent effect N-acetylcysteine NAC Fenoldopam Dopamine Calcium channel blockers Amlodipine Felodipine Nifedipine Nitrendipine Atrial natriuretic peptide L-Arginine Negative results Potentially detrimental Furosemide Mannitol Endothelin receptor antagonist Taken front: Strategies to Reduce the Risk of contrast-Induced Nephropathy: The CIN Consensus Working Panel 